In a crossover trial of 38 adults with mild-to-moderate ulcerative colitis, 28 days of 2'-fucosyllactose vs maltodextrin placebo showed no clear effect on conventional clinical indices but raised Bifidobacterium abundance (effect size 4.4%) and patient-reported disease control.
RCTn = 38
Kennedy et al. 2'-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial